![]() | When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment. |
08-Mar-2011 - GEA Pharma Systems, the German drug processing equipment manufacturer, has signed a representation agreement with Swedish hi-tech firm Christian Berner Tech Trade.
07-Mar-2011 - CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).
03-Mar-2011 - The WHO expects global vaccine supplies will benefit significantly after it approved the Chinese SFDA regulatory system.
01-Mar-2011 - Generic drugmaker SOHM has expanded its manufacturing capacity for “lifestyle” diseases to meet growing Indian demand.
24-Feb-2011 - Clariant International has set up a unit to help the pharma sector overcome regulatory hurdles involved with developing colour packaging
24-Feb-2011 - Mass-market drug manufacturers can turn a fixed cost into a service-providing revenue generator by investing in an agile supply chain, says PwC.
22-Feb-2011 - AstraZeneca has become the latest drug firm to invest in Russian manufacturing capcity with the announcment of plans for a $150m facility in the country’s Kaluga region.
22-Feb-2011 - A radical overhaul of pharmaceutical supply chains is needed to prepare them for the type of products currently in development, says PwC.
21-Feb-2011 - The US HHS has published a national vaccine plan that stresses the need for rapid and flexible manufacturing methods.
21-Feb-2011 - Operating profit at West tumbled in the fourth quarter as restructuring charges and the lack of H1N1 affected results.
17-Feb-2011 - The European Parliament has approved the falsified medicines directive and described it as a “huge step” in efforts to protect patients.
16-Feb-2011 - French drugmaker Sanofi Aventis will buy Genzyme after the firms finally agree a valuation based on manufacturing performance, approvals and sales.
16-Feb-2011 - Japanese pharma giant, Daiichi Sankyo Inc. (DSI) has announced the acquisition of its first US-based packaging and manufacturing plant.
16-Feb-2011 - EMD Serono Inc., an affiliate of pharma giant Merck, has announced the opening of a new research centre in Massachusetts, US.
16-Feb-2011 - Canada lost more than 3,600 pharmaceutical jobs in the second half of 2010 as domestic and export sales slowed.
15-Feb-2011 - Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.
14-Feb-2011 - Gerresheimer has reported sales and earnings growth for the fiscal year 2010, citing demand from customers in the pharmaceutical industry as key.
14-Feb-2011 - Variation between drug batches in developing countries poses “serious clinical implications” and should be tackled by regulators.
09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.
09-Feb-2011 - The United States Pharmacopeoia (USP) will help regulators in sub-Saharan Africa ensure drug quality in a new scheme designed to boost testing and analysis capacity.
09-Feb-2011 - A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.
08-Feb-2011 - More collaborative biosurveillance could save billions of dollars and millions of lives by, for example, cutting pandemic strain isolation times.
07-Feb-2011 - Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.
07-Feb-2011 - US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.
03-Feb-2011 - Ugandan drugmaker Quality Chemicals Industries (QCI) will invest $80m in manufacturing operations to boost capacity for the production of generic AIDS and malaria drugs.